Medscape reported on Friday that dupilumab eases ear disease in patients with nasal polyps. The outlet published the finding under the headline "Dupilumab Eases Ear Disease in Nasal Polyp Patients," dated October 2, 2026.
According to Medscape, the report concerns people who have nasal polyps — growths in the nasal passages — and who also show signs of ear disease. The outlet's summary states that the drug eased that ear condition in these patients.
The material available does not specify how many patients were involved, how the study was designed, which ear symptoms improved, or how large any measured effect was. It also does not identify the researchers, the institutions involved, or where the work was presented or published.
Dupilumab is a prescription medicine, and Medscape's report frames the finding around its use in patients with nasal polyps. The outlet's summary does not describe the drug's approved uses, its side effects, or how it was given in this setting.
Medscape has not released the full article text alongside the headline and summary. That means the underlying data, the study population, and any comparison against placebo or standard care remain unverified from the material available.
Further reporting from Medscape is expected to carry the study details behind the claim. Until those details appear, the finding should be read as Medscape's summary of a reported result rather than a complete account of the evidence.
